Acknowledgement
Supported by : 미래창조과학부, 보건복지부
References
- Emilsson, Valur, et al., "Genetics of gene expression and its effect on disease," Nature, Vol. 452, No. 7186, pp. 423-428, 2008. https://doi.org/10.1038/nature06758
- Tibshirani, Robert, "Regression shrinkage and selection via the lasso," Journal of the Royal Statistical Society. Series B (Methodological), pp. 267- 288, 1996.
- Park, Cheolyong, "Simple Principal component analysis using Lasso," Journal of the Korean Data and Information Science Society, Vol. 24, No. 3, pp. 533- 541, 2013. (in Korean) https://doi.org/10.7465/jkdi.2013.24.3.533
- Bach, Francis R., "Bolasso: model consistent lasso estimation through the bootstrap," Proc. of the 25th International Conference on Machine Learning, ACM, pp. 33-40, 2008.
- Zou, Hui, "The adaptive lasso and its oracle properties," Journal of the American Statistical Association, Vol. 101, No. 476, pp. 1418-1429, 2006. https://doi.org/10.1198/016214506000000735
- Nam, R. K., et al., "Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer," British Journal of Cancer, Vol. 97, No. 12, pp. 1690-1695, 2007. https://doi.org/10.1038/sj.bjc.6604054
- Wang, Yixin, et al., "Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer," Journal of Clinical Oncology, Vol. 22, No. 9, pp. 1564-1571, 2004. https://doi.org/10.1200/jco.2004.22.14_suppl.1564
- Beer, D. G. et al., "Gene-expression profiles predict survival of patients with lung adenocarcinoma," Nature Medicine, Vol. 8, No. 8, pp. 816-824, 2002. https://doi.org/10.1038/nm733
- Efron, Bradley, "Bootstrap Methods: Another Look at the Jackknife," The Annals of Statistics, pp. 1-26, 1979.
- Ader, Herman J., and Mellenbergh Ader, "Advising on research methods: A consultant's companion," Johannes van Kessel Publishing, pp. 371-373, 2008.
- Paik, S. et al., "A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer," New England Journal of Medicine, Vol. 351, No. 27, pp. 2817-2826, 2004. https://doi.org/10.1056/NEJMoa041588
- Robinson, Mark D., Davis J. McCarthy, and Gordon K. Smyth, "edgeR: a Bioconductor package for differential expression analysis of digital gene expression data," Bioinformatics, Vol. 26, No. 1, pp. 139-140, 2010. https://doi.org/10.1093/bioinformatics/btp616
- Cheng, J. et al., "Good practice guidelines for biomarker discovery from array data: a case study for breast cancer prognosis," BMC Systems Biology, Vol. 7, No. 4, p. S2, 2013.
- Aguiar, Ernestina Silva de, et al., "GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening," Revista Brasileira de Epidemiologia, Vol. 15, No. 2, pp. 246-255, 2012. https://doi.org/10.1590/S1415-790X2012000200002
- Mohammed, Hisham, et al., "Progesterone receptor modulates ER [agr] action in breast cancer," Nature, Vol. 523, No. 7560, pp. 313-317, 2015. https://doi.org/10.1038/nature14583
- Cheng, Chien-Jui, et al., "SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer," Cancer Research, Vol. 69, No. 8, pp. 3634-3641, 2009. https://doi.org/10.1158/0008-5472.CAN-08-3615
- Majidzadeh-A, Keivan, Rezvan Esmaeili, and Nasrin Abdoli, "TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer," BMC Research Notes, Vol. 4, No. 1, p. 215, 2011. https://doi.org/10.1186/1756-0500-4-215
- Dawson, Sarah-Jane, et al., "BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received," British Journal of Cancer, Vol. 103, No. 5, pp. 668-675, 2010. https://doi.org/10.1038/sj.bjc.6605736
- Robinson, Dan R., et al., "Activating ESR1 mutations in hormone-resistant metastatic breast cancer," Nature Genetics, Vol. 45, No. 12, pp. 1446-1451, 2013. https://doi.org/10.1038/ng.2823
- Zhang, Zhan-Guo, et al., "MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1," Biochemical and Biophysical Research Communications, Vol. 454, No. 1, pp. 109-114, 2014. https://doi.org/10.1016/j.bbrc.2014.10.049
- Cheng, Chun-Wen, et al., "The clinical implications of MMP-11 and CK-20 expression in human breast cancer," Clinica Chimica Acta, Vol. 411, No. 3, pp. 234-241, 2010. https://doi.org/10.1016/j.cca.2009.11.009
- Turner, Bruce C., et al., "BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer," Journal of Clinical Oncology, Vol. 19, No. 4, pp. 992-1000, 2001. https://doi.org/10.1200/JCO.2001.19.4.992
- Menzl, Ina, et al., "Loss of primary cilia occurs early in breast cancer development," Cilia, Vol. 3, No. 1, p. 7, 2014. https://doi.org/10.1186/2046-2530-3-7
- Gevaert, O., Smet, F. D., Timmerman, D., Moreau, Y., and Moor, B. D., "Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks," Bioinformatics, Vol. 22, No. 14, e184-190, 2006. https://doi.org/10.1093/bioinformatics/btl230
- Fukukawa, C., Ueda, K., Nishidate, T., Katagiri, T., and Nakamura, Y., "Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells," Genes, Chromosomes and Cancer, Vol. 49, No. 10, pp. 861-872, 2010. https://doi.org/10.1002/gcc.20795